Baby Instituttet ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2017
2018/4
2018
2019/4
2019
2020/4
2020
2021/4
2021
2022/4
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  9.4% 7.5% 7.2% 15.4% 7.5%  
Credit score (0-100)  28 34 35 13 31  
Credit rating  BB BB BBB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2017
2018/4
2018
2019/4
2019
2020/4
2020
2021/4
2021
2022/4

Net sales  0 0 0 0 0  
Gross profit  3,229 4,080 5,358 6,519 5,910  
EBITDA  123 485 165 -578 -96.9  
EBIT  64.6 472 80.9 -677 -260  
Pre-tax profit (PTP)  29.2 454.5 80.9 -684.0 -315.7  
Net earnings  22.8 354.4 61.7 -533.9 -234.5  
Pre-tax profit without non-rec. items  29.2 455 80.9 -684 -316  

 
See the entire income statement

Balance sheet (kDKK) 
2017
2018/4
2018
2019/4
2019
2020/4
2020
2021/4
2021
2022/4

Tangible assets total  23.0 10.4 159 456 292  
Shareholders equity total  -313 41.2 103 -431 -665  
Interest-bearing liabilities  653 0.0 0.0 604 1,541  
Balance sheet total (assets)  795 613 1,209 1,922 1,883  

Net Debt  311 -167 -488 460 1,335  
 
See the entire balance sheet

Volume 
2017
2018/4
2018
2019/4
2019
2020/4
2020
2021/4
2021
2022/4

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  3,229 4,080 5,358 6,519 5,910  
Gross profit growth  50.0% 26.4% 31.3% 21.7% -9.3%  
Employees  0 0 0 13 12  
Employee growth %  0.0% 0.0% 0.0% 0.0% -7.7%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  795 613 1,209 1,922 1,883  
Balance sheet change%  42.9% -22.9% 97.2% 59.0% -2.0%  
Added value  122.7 484.5 164.7 -592.9 -96.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -116 -25 65 197 -327  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 -1.0 -2.0  

Profitability 
2017
2018/4
2018
2019/4
2019
2020/4
2020
2021/4
2021
2022/4
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  2.0% 11.6% 1.5% -10.4% -4.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  6.5% 54.8% 8.9% -38.0% -10.6%  
ROI %  12.1% 135.9% 112.2% -128.1% -17.4%  
ROE %  3.4% 84.8% 85.6% -52.7% -12.3%  

Solidity 
2017
2018/4
2018
2019/4
2019
2020/4
2020
2021/4
2021
2022/4
Equity ratio %  -30.5% 6.7% 8.5% -18.3% 18.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  253.1% -34.4% -296.2% -79.7% -1,377.9%  
Gearing %  -208.6% 0.0% 0.0% -140.2% -231.6%  
Net interest  0 0 0 0 0  
Financing costs %  6.6% 5.3% 0.0% 2.4% 5.2%  

Liquidity 
2017
2018/4
2018
2019/4
2019
2020/4
2020
2021/4
2021
2022/4
Quick Ratio  0.6 0.5 0.5 0.2 0.5  
Current Ratio  0.7 1.1 0.9 0.5 1.0  
Cash and cash equivalent  342.6 166.9 487.7 144.2 206.0  

Capital use efficiency 
2017
2018/4
2018
2019/4
2019
2020/4
2020
2021/4
2021
2022/4
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -336.2 30.8 -103.8 -1,020.4 44.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2017
2018/4
2018
2019/4
2019
2020/4
2020
2021/4
2021
2022/4
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 -46 -8  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 -44 -8  
EBIT / employee  0 0 0 -52 -22  
Net earnings / employee  0 0 0 -41 -20